Analysis Metabolite Name Measured Value Units Cell Type Stimulation
Reversed phase NEGATIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M-H)-13529Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M-H)-16089Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M-H)-Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M-H)-Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M-H)-Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M-H)-Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M-H)-Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M-H)-Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M-H)-Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M-H)-Peak areaHAHA Untreated
Reversed phase NEGATIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M-H)-Peak areaPAK IFN-G
Reversed phase NEGATIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M-H)-Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M-H)-Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M-H)-Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M-H)-Peak areaPAK Untreated
Reversed phase NEGATIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M-H)-13529Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M-H)-16089Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M-H)-Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M-H)-Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M-H)-Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M-H)-Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M-H)-Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M-H)-Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M-H)-Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M-H)-Peak areaHAHA Untreated
Reversed phase NEGATIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M-H)-Peak areaPAK IFN-G
Reversed phase NEGATIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M-H)-Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M-H)-Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M-H)-Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M-H)-Peak areaPAK Untreated

Return to search page
  logo